| Bioactivity | Evogliptin hydrochloride (DA-1229 hydrochloride) is an orally active dipeptidyl peptidase 4 (DPP-4) inhibitor. By suppressing the activity of the DPP-4, Evogliptin hydrochloride increases the levels of endogenous GLP-1, improves insulin resistance, and decreases blood glucose levels. Evogliptin hydrochloride is utilized in the research of type 2 diabetes mellitus[1]. |
| CAS | 1246960-27-9 |
| Formula | C19H27ClF3N3O3 |
| Molar Mass | 437.88 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kim M K, et al. Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models[J]. Archives of pharmacal research, 2017, 40(2): 268-281. |
Evogliptin hydrochloride
CAS: 1246960-27-9 F: C19H27ClF3N3O3 W: 437.88
Evogliptin hydrochloride (DA-1229 hydrochloride) is an orally active dipeptidyl peptidase 4 (DPP-4) inhibitor. By suppre
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.